Russell Investments Group Ltd. Has $22.17 Million Position in LeMaitre Vascular, Inc. $LMAT

Key Points

• Russell Investments Group Ltd. increased its holdings in LeMaitre Vascular by 11.6%, owning about 1.17% of the company, worth approximately $22.17 million as of the latest SEC filing.
• LeMaitre Vascular recently reported a quarterly earnings per share (EPS) of $0.60, exceeding analyst expectations, with revenues rising 15.0% year-over-year to $63.15 million.
• The company announced a quarterly dividend of $0.20 per share, representing an annual yield of 0.8%, with a payout ratio of 38.83%.

Russell Investments Group Ltd. boosted its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 11.6% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 264,261 shares of the medical instruments supplier's stock after purchasing an additional 27,470 shares during the period. Russell Investments Group Ltd. owned 1.17% of LeMaitre Vascular worth $22,172,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in LMAT. Raymond James Financial Inc. purchased a new position in LeMaitre Vascular during the 4th quarter worth approximately $14,900,000. Invesco Ltd. grew its position in LeMaitre Vascular by 34.5% during the 1st quarter. Invesco Ltd. now owns 235,436 shares of the medical instruments supplier's stock worth $19,753,000 after purchasing an additional 60,438 shares in the last quarter. Nuveen LLC purchased a new position in shares of LeMaitre Vascular during the 1st quarter valued at $4,631,000. GAMMA Investing LLC grew its holdings in shares of LeMaitre Vascular by 7,486.5% during the 1st quarter. GAMMA Investing LLC now owns 53,864 shares of the medical instruments supplier's stock valued at $4,519,000 after acquiring an additional 53,154 shares in the last quarter. Finally, Millennium Management LLC grew its holdings in shares of LeMaitre Vascular by 96.8% during the 4th quarter. Millennium Management LLC now owns 96,081 shares of the medical instruments supplier's stock valued at $8,853,000 after acquiring an additional 47,250 shares in the last quarter. 84.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Cantor Fitzgerald boosted their price target on shares of LeMaitre Vascular from $92.00 to $95.00 and gave the company a "neutral" rating in a report on Wednesday, August 6th. Barrington Research upgraded shares of LeMaitre Vascular from a "market perform" rating to an "outperform" rating and set a $95.00 price target on the stock in a report on Wednesday, August 6th. Two investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, LeMaitre Vascular currently has a consensus rating of "Hold" and an average target price of $97.60.

LeMaitre Vascular Stock Up 1.4%

NASDAQ:LMAT traded up $1.3150 during trading hours on Wednesday, reaching $96.6450. The company's stock had a trading volume of 135,583 shares, compared to its average volume of 188,803. The company has a market cap of $2.19 billion, a price-to-earnings ratio of 46.92, a price-to-earnings-growth ratio of 2.44 and a beta of 0.79. LeMaitre Vascular, Inc. has a one year low of $71.42 and a one year high of $109.58. The business's 50-day moving average is $85.03 and its 200-day moving average is $86.39. The company has a debt-to-equity ratio of 0.46, a current ratio of 13.96 and a quick ratio of 11.74.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.57 by $0.03. The firm had revenue of $63.15 million during the quarter, compared to analysts' expectations of $62.48 million. LeMaitre Vascular had a net margin of 20.08% and a return on equity of 13.67%. LeMaitre Vascular's revenue for the quarter was up 15.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.52 earnings per share. LeMaitre Vascular has set its Q3 2025 guidance at 0.540-0.590 EPS. FY 2025 guidance at 2.230-2.370 EPS. Equities research analysts predict that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

LeMaitre Vascular Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 4th. Shareholders of record on Thursday, August 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Thursday, August 21st. This represents a $0.80 dividend on an annualized basis and a yield of 0.8%. LeMaitre Vascular's payout ratio is currently 38.83%.

Insider Activity

In other LeMaitre Vascular news, Director Bridget A. Ross sold 2,500 shares of the business's stock in a transaction on Friday, August 8th. The shares were sold at an average price of $94.00, for a total transaction of $235,000.00. Following the completion of the transaction, the director owned 2,916 shares of the company's stock, valued at $274,104. The trade was a 46.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David B. Roberts sold 10,815 shares of the company's stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $92.39, for a total transaction of $999,197.85. Following the transaction, the director directly owned 17,976 shares of the company's stock, valued at $1,660,802.64. This represents a 37.56% decrease in their position. The disclosure for this sale can be found here. Insiders sold 120,815 shares of company stock worth $11,280,206 in the last 90 days. Insiders own 9.50% of the company's stock.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.